Jul. 27 at 9:44 PM
$NRSN I know shareholders would be happy now at a
$1.00 buyout at this point, Alon is pathetic, just sell the company bro, if you really care about ALS sell it off.
Stop waiting, you delayed this trial for 2 years, it could have been in the market by now, your team lacks experience as a company
This long-term survival metric you keep boasting about of 15 months from phase 2, well guess what buddy, it’s been a lot more than 15 months since this trial was supposed to start.
Just seriously sell this off, and move on somewhere else, you clearly do not have the leadership nor capital to execute this, not for the shareholders, but for the actual patients.
You did what you can, just move on and sell it off.